OLMAHealthcareSmall-Cap
Olema Pharmaceuticals, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Olema Pharmaceuticals, Inc. (OLMA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are OLMA insiders buying or selling?
Olema Pharmaceuticals, Inc. insiders reported 12 open-market buys ($84.0M) and 61 sells ($100.3M) across 73 Form 4 filings — a net selling position of $16.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 6, 2026)
Total Form 4 filings
73
SEC EDGAR
Insider filers
12
Insider buys (12)
$84.0M
Insider sells (61)
$100.3M
Insider sentiment
Net sellingNet insider flow of $16.3M in net selling.
Recent OLMA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | Shawnte Mitchell | CHIEF LEGAL OFFICER | Sale | 40.0K | $23.79 | $951.5K |
| Jan 22, 2026 | Cyrus Harmon | Director | Sale | 10.0K | $26.88 | $268.8K |
| Jan 17, 2026 | Cyrus Harmon | Director | Sale | 3.5K | $29.12 | $101.6K |
| Jan 16, 2026 | Shane William Charles Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale | 103.8K | $28.70 | $3.0M |
| Jan 15, 2026 | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 110.0K | $28.25 | $3.1M |
| Sep 19, 2025 | Cyrus Harmon | Director | Sale | 25.0K | $8.19 | $204.8K |
| Jan 13, 2025 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Purchase | 300.0K | $5.76 | $1.7M |
| Dec 18, 2024 | Graham G. Walmsley | Director | Sale | 1.4M | $6.75 | $9.5M |
| Dec 12, 2024 | Cyrus Harmon | Director | Sale | 16.4K | $9.03 | $148.0K |
| Dec 12, 2024 | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 26.1K | $9.01 | $234.9K |
| Dec 12, 2024 | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale | 27.8K | $9.01 | $250.5K |
| Dec 12, 2024 | Shane William Charles Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale | 35.2K | $9.01 | $316.7K |
| Dec 12, 2024 | Sean Bohen | PRESIDENT AND CEO | Sale | 109.5K | $9.01 | $986.4K |
| Nov 26, 2024 | Graham G. Walmsley | Director | Sale | 1.2M | $14.85 | $17.4M |
| Aug 5, 2024 | Senai Asefaw | 10% Owner | Sale | 2.4M | $14.92 | $35.8M |
| Jul 31, 2024 | Cyrus Harmon | Director | Sale | 5.0K | $15.57 | $77.9K |
| Jul 12, 2024 | Cyrus Harmon | Director | Sale | 5.0K | $12.26 | $61.3K |
| Jul 2, 2024 | Cyrus Harmon | Director | Sale | 20.0K | $10.77 | $215.4K |
| Jun 6, 2024 | Graham G. Walmsley | Director | Sale | 1.2M | $14.85 | $17.4M |
| Jun 5, 2024 | Cyrus Harmon | Director | Sale | 25.0K | $10.30 | $257.4K |
| May 7, 2024 | Cyrus Harmon | Director | Sale | 5.0K | $10.92 | $54.6K |
| May 2, 2024 | Cyrus Harmon | Director | Sale | 15.0K | $9.51 | $142.7K |
| Mar 29, 2024 | Cyrus Harmon | Director | Sale | 20.0K | $10.97 | $219.4K |
| Mar 4, 2024 | Cyrus Harmon | Director | Sale | 25.0K | $12.41 | $310.3K |
| Feb 2, 2024 | Cyrus Harmon | Director | Sale | 30.0K | $12.79 | $383.6K |
Showing the 25 most recent of 73 Form 4 filings for Olema Pharmaceuticals, Inc..
Most active OLMA insiders
- Cyrus Harmon28 filings
- Kinney Horn10 filings
- David C. Myles7 filings
- Sean Bohen7 filings
- Graham G. Walmsley5 filings
Ask anything about OLMA insider activity
Use Trabud's AI agent to query Olema Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me OLMA CEO purchases this year" or compare it against any other ticker.
Open the AI agentOLMA insider trading FAQ
Are Olema Pharmaceuticals, Inc. insiders buying or selling?
Across 73 SEC Form 4 filings, Olema Pharmaceuticals, Inc. (OLMA) insiders reported 12 open-market purchases totaling $84.0M and 61 sales totaling $100.3M. That is a net selling position of $16.3M.
How many insiders trade OLMA stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Olema Pharmaceuticals, Inc.. The most recent filing was accepted on Mar 6, 2026.
Where does Trabud get OLMA insider trading data?
All OLMA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.